Central Glass (4044) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
10 Aug, 2026Executive summary
Net sales for Q1 FY2026 reached 37,763 million yen, up 13.2% year-over-year, driven by growth in Electronic Materials, Energy Materials, and Applied Chemicals, despite lower Medi-Chemicals sales and supported by proactive sales and efficiency improvements.
Operating profit rose to 3,958 million yen, an increase of 149.4% year-over-year, mainly from Electronic Materials and Applied Chemicals.
Ordinary profit and profit before income taxes both increased to 4,875 million yen, up 173.7% year-over-year.
Profit attributable to owners of parent surged to 3,906 million yen, up 368.3% year-over-year.
Comprehensive income for Q1 FY2026 was 6,664 million yen, up from 541 million yen a year earlier.
Financial highlights
Gross profit increased from 8,688 million yen to 11,240 million yen year-over-year.
R&D expenses remained flat at 1,900 million yen.
Exchange rate shifted from 145 to 160 JPY/USD; crude oil price rose from $72.6 to $104.3 per barrel.
Total assets increased to 201,798 million yen, with net assets up to 132,509 million yen.
Interest-bearing debt decreased by 1,106 million yen to 28,800 million yen.
Outlook and guidance
Full-year net sales forecast revised upward to 167,500 million yen, up 15.9% year-over-year and 3,500 million yen from initial guidance.
Full-year operating profit forecast raised to 11,000 million yen, up 9.7% year-over-year and 1,000 million yen from initial guidance.
Profit attributable to owners of parent expected to decrease 4.3% to 8,000 million yen.
Upward revisions reflect strong sales trends, especially in specialty gases for Electronic Materials, despite some weakness in Energy Materials.
Annual dividend forecast set at 170 yen per share, the highest in company history.
Latest events from Central Glass
- Operating profit and EPS rose despite lower sales; full-year outlook remains cautious.4044
Q1 2024 - Profits and sales fell sharply, prompting a downward revision of the full-year outlook.4044
Q3 2024 - Sales and profits fell sharply, but operating cash flow and equity ratio improved.4044
Q2 2024 - Profits fell sharply on lower sales, but dividends are maintained amid market uncertainty.4044
Q4 2024 - Profits fell sharply on lower sales and a major subsidiary sale will trigger an extraordinary loss.4044
Q1 2025 - Operating profit fell 47.3% year-over-year amid lower sales and segment restructuring.4044
Q2 2025 - Mixed segment results and lower profits, but improved equity ratio and revised guidance.4044
Q3 2025 - Profit surged on stable sales, but cost pressures and segment shifts shape a cautious outlook.4044
Q4 2025